Corrigendum to "Development and Application of an UHPLC-MS/MS Method for Comparative Pharmacokinetic Study of Eight Major Bioactive Components from Yin Chen Hao Tang in Normal and Acute Liver Injured Rats"

Affiliations

¹ Hebei Institute for Drug Control, No. 16 Fuqiang Street, Shijiazhuang 050011, China.
² School of Pharmacy, Second Military Medical University, No. 325 Guohe Road, Shanghai 200433, China.
³ Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China.
⁴ Postdoctoral Research Workstation, 210th Hospital of the Chinese People's Liberation Army, Dalian 116021, China.

Published Erratum

Yun Wang et al. Evid Based Complement Alternat Med. 2018.

. 2018 Dec 16:2018:3024841.

doi: 10.1155/2018/3024841. eCollection 2018.

¹ Hebei Institute for Drug Control, No. 16 Fuqiang Street, Shijiazhuang 050011, China.
² School of Pharmacy, Second Military Medical University, No. 325 Guohe Road, Shanghai 200433, China.
³ Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China.
⁴ Postdoctoral Research Workstation, 210th Hospital of the Chinese People's Liberation Army, Dalian 116021, China.

Abstract

[This corrects the article DOI: 10.1155/2018/3239785.].

Development and Application of an UHPLC-MS/MS Method for Comparative Pharmacokinetic Study of Eight Major Bioactive Components from Yin Chen Hao Tang in Normal and Acute Liver Injured Rats.
Wang Y, Xing X, Cao Y, Zhao L, Sun S, Chen Y, Chai Y, Chen S, Zhu Z. Wang Y, et al. Evid Based Complement Alternat Med. 2018 Nov 1;2018:3239785. doi: 10.1155/2018/3239785. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30519262 Free PMC article.

1. Wang Y., Xing X., Cao Y., et al. Development and application of an UHPLC-MS/MS method for comparative pharmacokinetic study of eight major bioactive components from yin chen hao tang in normal and acute liver injured rats. Evidence-Based Complementary and Alternative Medicine. 2018;2018:12. doi: 10.1155/2018/3239785.3239785 - DOI - PMC - PubMed